These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8236507)

  • 1. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
    Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
    Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of HBME-1 immunostaining in serous effusions.
    Ascoli V; Carnovale-Scalzo C; Taccogna S; Nardi F
    Cytopathology; 1997 Oct; 8(5):328-35. PubMed ID: 9313985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical identification of cells in serous effusions. Technical considerations.
    Li CY; Lazcano-Villareal O; Pierre RV; Yam LT
    Am J Clin Pathol; 1987 Dec; 88(6):696-706. PubMed ID: 2446492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOC31 Immunostaining in the Diagnosis of Metastatic Adenocarcinoma in Serous Fluid: Special Emphasis on Atypical Cytological Cases.
    Sahu S; Sharma S; Gupta P; Dey P
    Acta Cytol; 2021; 65(3):242-249. PubMed ID: 33827073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
    Erkiliç S; Koçer NE
    Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
    Kaur K; Patel T; Patra S; Trivedi P
    Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
    Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4.
    Illingworth AL; Young JA; Johnson GD
    Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic analysis of serous effusion cells by scanning electron microscopy.
    Cappellari A; Furlan C; Cardellini P; Bagarella M; Corradi G
    Tumori; 1992 Feb; 78(1):10-2. PubMed ID: 1609452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
    Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
    Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases.
    Diaz-Arias AA; Loy TS; Bickel JT; Chapman RK
    Diagn Cytopathol; 1993 Oct; 9(5):516-21. PubMed ID: 8287759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.
    Linari A; Bussolati G
    J Clin Pathol; 1989 Nov; 42(11):1184-9. PubMed ID: 2685053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
    Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
    Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
    Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.